Picture of Tandem Diabetes Care logo

TNDM — Tandem Diabetes Care News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Tandem Diabetes Care Announces FDA Clearance Of Control-IQ+ Automated Insulin Delivery Tech

Feb 25 (Reuters) - Tandem Diabetes Care Inc TNDM.O:

TANDEM DIABETES CARE ANNOUNCES FDA CLEARANCE OF CONTROL-IQ+ AUTOMATED INSULIN DELIVERY TECHNOLOGY FOR PEOPLE WITH TYPE 2 DIABETES

TANDEM DIABETES CARE INC: CONTROL-IQ+ IS EXPECTED TO BE AVAILABLE FOR NEW AND EXISTING CUSTOMERS IN UNITED STATES IN MARCH 2025

Source text: ID:nBw934rdga

Further company coverage: TNDM.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Tandem Diabetes Care

See all news